Bausch Health Companies Inc. (BHC)
NYSE · Healthcare
Bausch Health Companies Inc. EBITDA 2008–2025
Bausch Health Companies Inc. annual/quarterly ebitda history and growth rate from 2009 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Bausch Health Companies Inc. ebitda for the quarter ending March 31, 2026 was -655.0 M, a 212.74% decrease year-over-year.
- Bausch Health Companies Inc. ebitda for the twelve months ending March 31, 2026 was 1.0 B, a 56.87% decrease year-over-year.
- Bausch Health Companies Inc. annual ebitda for 2025 was 3.0 B, a 7.39% increase from 2024.
- Bausch Health Companies Inc. annual ebitda for 2024 was 2.8 B, a 26.31% increase from 2023.
- Bausch Health Companies Inc. annual ebitda for 2023 was 2.2 B, a 20.51% increase from 2022.
- Bausch Health Companies Inc. annual ebitda for 2022 was 1.8 B.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Bausch Health Companies Inc. EBITDA — FAQ
Bausch Health Companies Inc. (BHC) ebitda over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BHC's ebitda history?
The chart and table above show Bausch Health Companies Inc.'s ebitda by year and by quarter, including the growth rate.